Lpath Inc fka LPTN

[stockmasterflash]

Pancoast

Just got hired by a BK11 pennystock scam

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126899752

Scott R. Pancoast Joins the Imaging3 Team

Imaging3, Inc. (OTCQB:IGNG) announced today that it has entered into a consulting agreement with Scott R. Pancoast, whereby Mr. Pancoast will serve as special advisor to the company's executive team and its board of directors. Once the company has secured directors and officers insurance, Mr. Pancoast will be named executive chairman of the board, where he will also have an executive role; at that time, Dane Medley, currently chief executive officer and president, will relinquish his CEO role and remain president.

Scott Pancoast most recently served as chief executive officer and board member of Lpath, Inc., a biotech start-up, where he built a world-class team of executives that: took Lpath public and later uplisted it to Nasdaq; forged partnerships with Pfizer, Biogen Idec, Merck-Serono, and the Department of Defense; and raised over $150 million through private and public offerings, government grants, and collaborations. Prior to that, Mr. Pancoast served as executive vice president of Western States Investment Group, a privately owned venture-investment firm, whose holdings included the start-up that introduced the "ear thermometer" [sold to Wyeth/Pfizer]; an RFID start-up that had a leading position in the electronic vehicle-identification market [sold to a JP Morgan fund]; and a medical-device start-up that designed diagnostic and therapeutic devices for gastro-esophageal reflux disease [sold to Medtronic]. In his career, Mr. Pancoast has served on the board of directors of over 15 entities, including three public companies, and been CEO or interim CEO for seven entities. He is a graduate of the University of Virginia, summa cum laude, and the Harvard Business School, with honors.

Dane Medley stated, "We are extremely gratified to have someone with Scott's background and pedigree join the Imaging3 team. Scott shares our vision of Imaging3 bringing a disruptive technology to the radiology marketplace and consequently achieving sizable market share, while at the same time improving the quality of healthcare, especially for children."

Added Scott Pancoast, "I was presented with many opportunities over the last couple of years, but it was the promise of Imaging3 that brought me out of retirement. After conducting extensive due diligence, I am convinced of the upside potential of Imaging3's technology, and I look forward to working with Dane as we build out the management team and position the company for success."

[KantKill]

I have no malicious intent whatsoever, I am not sure even whats happening.

[KantKill]

Things may not be all bad, some of us just felt like it was kind of the Apollo show w/ LPTN makng guest appearances --- I guess when LPTN only makes up 4%.1 or 4.2% (dpenending on cash vs debt at completion) it makes sense --

Sold near 4, but lookin for possible re-entry...


Someone please post with some good news, half my reason for stating as such is to have someone swoop in to save the day with a better understanding of the situation as I've only gone skin deep.

[KantKill]

The S4 is bad news for LPTN shareholders ---

This is a joke, its as if its written solely to Apollo... Please correct me if, and where I am wrong...

A reverse split? 80 cent share price ? (separate points)

To the Stockholders of Lpath, Inc. and Apollo Endosurgery, Inc.:

Lpath, Inc. ("Lpath") and Apollo Endosurgery, Inc. ("Apollo") have entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") pursuant to which a wholly-owned subsidiary of Lpath will merge with and into Apollo, with Apollo surviving as a wholly-owned subsidiary of Lpath (the "merger"). Apollo and Lpath believe that the merger will result in a medical device company focused on the development and global distribution of less invasive products used in the treatment of obesity and other gastrointestinal disorders.

Immediately prior to the effective time of the merger, each share of Apollo preferred stock will be converted into shares of Apollo common stock at a ratio determined in accordance with the Apollo certificate of incorporation then in effect. At the effective time of the merger, each share of Apollo common stock will be converted into the right to receive an estimated 0.314 shares of Lpath common stock (the "exchange ratio"), subject to adjustment to account for the effect of a reverse stock split of Lpath common stock, at a ratio of one new share for every five and one half shares outstanding (1:5.5), to be implemented prior to the consummation of the merger as discussed in this proxy statement/prospectus/information statement. The estimated exchange ratio calculation contained herein is based upon Lpath's capitalization immediately prior to the date of this proxy statement/prospectus/information statement, and will be adjusted to account for the issuance of any additional shares of Lpath common stock prior to the consummation of the merger. Lpath will assume outstanding and unexercised warrants to purchase Apollo capital stock and options to purchase Apollo common stock, and they will be converted into warrants and options, as applicable, to purchase Lpath common stock. Lpath stockholders will continue to own and hold their existing shares of Lpath common stock. Immediately following the consummation of the merger, Apollo stockholders, warrantholders and optionholders will own approximately 95.8% of the fully-diluted common stock of Lpath, with Lpath stockholders, optionholders and warrantholders, whose shares of Lpath stock will remain outstanding after the merger, holding approximately 4.2% of the fully-diluted common stock of Lpath, subject to a reduction of 0.1% in the aggregate to Lpath stockholders, optionholders and warrantholders if Lpath's debt at the closing exceeds its net cash at the closing.

Shares of Lpath common stock are currently listed on The NASDAQ Capital Market under the symbol "LPTN." Prior to consummation of the merger, Lpath intends to file an initial listing application with The NASDAQ Global Market pursuant to NASDAQ "reverse merger" rules. After completion of the merger, Lpath will be renamed "Apollo Endosurgery, Inc." and expects to trade on The NASDAQ Global Market under the symbol "APEN." On , 2016, the last trading day before the date of this proxy statement/prospectus/information statement, the closing sale price of Lpath common stock was $ per share.

Lpath is holding a special meeting of stockholders in order to obtain the stockholder approvals necessary to complete the merger and related matters. At the Lpath special meeting, which will be held at a.m., Pacific Time, on , 2016 at , unless postponed or adjourned to a later date, Lpath will ask its stockholders to, among other things, adopt the Merger Agreement thereby approving the merger and the issuance of Lpath common stock, approve amendments to the Lpath amended and restated certificate of incorporation effecting a reverse stock split of Lpath common stock, at a ratio of one new share for every five and one half shares outstanding, which is referred to as the 1:5.5 reverse stock split, and an amendment to the amended and restated certificate of incorporation changing the Lpath corporate name to "Apollo Endosurgery, Inc.", and approve, on a non-binding advisory vote basis, compensation that will or may become payable by Lpath to its named

[stocktrademan]

fast and steady profit scan LPTN bullish 3.2801



normal chart


log chart

[ClearlyStocks]

LPTN $247 merger agreement with Apollo Endo

[stocktrademan]

LPTN bullish 2.35

stochastic5,3,3 oversold crossup scan

[Shaka_Zulu]

Target 5.88

[BillBadaass]

Intersting

[Stockexpertpro]

LPTN placed on Reg Sho list over 3 Million shares now sold short vs Tiny 1.9 Million share float

[ClayTrader]

* * $LPTN Video Chart 08-19-16 * *

Link to Video - click here to watch the technical chart video

[Love4Money]

Picked some up at 3.18.

[ClearlyStocks]

Craziness continues

[Shaka_Zulu]

Popping

[Betchips]

Did you pick up shares today?

[Betchips]

LPTN looking for strategic merger or buyout currently, book value significantly higher, could see a runner like STEM today on this low floater!

[Value_Investor]

LOL, LPTN is up 0.01 today! The BV is $3.71 v.s. trading at $2.05!

[Value_Investor]

LPTN just hit $2.65! How could it crash to $1.81 in the next day? 100% strong manipulations by those very sick MMs and greedy shorters!

[Value_Investor]

LPTN just hit $2.17! $2.65 should be tested again very soon...

[Value_Investor]

LOL, I even doubt if LPTN ever hit $2.65 just a week ago! There is a ridiculous trading behaviour here --- from $1.68 to $2.65 then within only a single day it crashed back to $1.81 without any bad news at all nor any market correction at all! It is a manipulation's haven...

[Value_Investor]

How could LPTN drop from $2.65 to $1.81 within only a day without any news at all? Very sick manipulations from the silly MMs!

[Value_Investor]

LOL, LPTN has $3.71 per share Huge Positive Book Value plus Zero Debt v.s. it is trading at the joke low $1.98 a share price now! Hyper Undervalued currently...

[Value_Investor]

How could the MMs manipulate LPTN down to as low as $1.81 from $2.65?

[Value_Investor]

LPTN is Hyper Undervalued now --- Debt-Free plus $3.71 Book Value and $2.97 Cash Value v.s. at the joke low low $2.0 ~ $2.11 today!

[Value_Investor]

LPTN had 39,600 shares shorted in the current month.

[Value_Investor]

LPTN had 25,700 shares shorted in the prior month.

[Value_Investor]

Not many shares were shorted as of 06/30/2016! But the number of shorting shares were increased by 54.42% from June 15 to June 30! They will be forced to chase to cover if LPTN breaks up $2.65 in the coming week...

http://shortsqueeze.com/?symbol=lptn

[Value_Investor]

LOL, the sick MM manipulated the price down to as low as $2.02 after LPTN hit the new high $2.65 today! This is the most sick manipulation I've ever seen for a Hyper Undervalued and Hyper Oversold hidden gem!

[Stockexpertpro]

LPTN Warning Shorting Low Float Bio Tech Stocks can be VERY DANGEROUS Just go ask the kid that got caught short KBIO and Loss Over 100,000$


http://www.businessinsider.com/joe-campbell-gofundme-page-for-e-trade-2015-11

[Value_Investor]

LPTN should close above $2.3 today since the high is $2.65!

[Value_Investor]

Wow, LPTN exploded to $2.65 today! It will test $3 next week!!

[tob999]

Crazy low $5.1M market cap!! Insane!

https://uk.finance.yahoo.com/q?s=LPTN

[Shaka_Zulu]

A close above 2.20 will be nice. Bullish to 2.96 then 4?

[tob999]

+21% on substantially increased volume! News comin?

[tob999]

Ibox updated and redesigned.

[tob999]

I can smarten up the Ibox if there are no objections. Any links to latest share structure and other pertinent info would be welcome.

[zino]

Float 2.O3 million !!!!!

[Value_Investor]

LPTN has Zero Debt which is a Sought-After Investment-Grade Nasdaq Bio-Tech stock while the majority of peers have heavy-loaded debts and the endless Huge Dilutions due to the debts conversions...

Hyper Undervalued now since LPTN has $3.71 per share Huge Book Value and $2.97 per share Huge Cash Value v.s. it is trading at the ridiculous low price $1.9099 now!

Hyper Oversold since LPTN just hit the most recent high $4.09! Easy double from here to hit $3.8x ~ $4.xx again...

LPTN has measly 1.9M shares Hyper Tiny float count which is an Hyper Rare find in the Nasdaq world! Easy double within a day as it did on June 20, 2016 --- see the chart below!

LPTN has mere 2.36M shares Hyper Tiny OS which is a Super rare find!

http://finance.yahoo.com/news/lpath-awarded-department-defense-grant-120200294.html

[tob999]

Good timing agreed! Bring on the boom..with this low sub 2M float it'll be a kaboom. These MM worms and other shorts won't know whats hit em!

[Value_Investor]

Nice entry at good timing! The Book Value of LPTN is almost double of the current ridiculous low price! The Cash Value is $2.97 a share!

[Value_Investor]

Yes. LPTN is Hyper Undervalued now --- $3.71 Huge BV v.s. at $1.91 ~ $2.02 today!

[zino]

bought in this morning...glta

[zino]

can fly here O/S 2,OOO,OOO

[Value_Investor]

We all saw that kinds of manipulation efforts almost everyday since LPTN declined from the most recent high $4.09 to $1.82 on July 7...

[tob999]

Undervalued indeed.

[Value_Investor]

LPTN hit the New high $2.04 so far! It has finally Bottomed out at the New low $1.68! $3.71 per share Huge Book Value! $2.97 per share Huge Cash Value!

http://finance.yahoo.com/news/lpath-awarded-department-defense-grant-120200294.html